In addition to STK11 mutations, KEAP1m identified as being associated with STK11 loss of function STK11 loss of function correlated to AXL activation and poorer outcomes in NSCLC BERGEN, Norway, April 18, 2023 /PRNewswire/ — BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.